Back to Authors

Fountaine, Robert J.

https://orcid.org/0000-0002-4105-1248

Mayo Clinic

Pfizer (United States)

Citations 2

Patient-reported Outcomes Through 12-weeks of Double-blind Rimegepant Treatment for the Prevention of Episodic Migraine in Adults with Prior Inadequate Response to Oral Preventatives (P1-15.008)
Starling, Amaal, Versijpt, Jan, Aslan, Ayşe Neslihan, Seehra, Harpreet, Ramaker, Sara Anne, McCollum, Shannin, Thiry, Alexandra, Abraham, Lucy, Fountaine, Robert, Ramirez, Luz, Versijpt, Jan J. , Sumelahti, Marja‐Liisa , Ramaker, Sara , Thiry, Alexandra, Abraham, Lucy , Fountaine, Robert J.

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000212882 Get It

Peripheral Neurological Safety of Subcutaneous Tanezumab versus Placebo or NSAIDs in Patients with Osteoarthritis. (1937)
Brown, Mark T. , Sandroni, Paola , Gorson, Kenneth C. , Low, Phillip A. , Pixton, Glenn C., Fountaine, Robert J. , Johnston, Elizabeth , Verburg, Kenneth M., Hunter, David J. , Viktrup, Lars , West, Christine R.

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1937 Get It